PepINVENT is an AI model developed by AstraZeneca and Chalmers University of Technology (United Kingdom and Sweden), first published in September 2024. It works in the biology domain, on tasks such as protein generation and protein design.
Epoch AI has no training-compute estimate for this model. Training ran on NVIDIA V100.
Access: Open weights (unrestricted). Its weights are openly available. The reference paper has 17 citations. Epoch AI rates the confidence of this record as confident.